INSMED INC Capital Expenditures
INSMED INC (INSM) reported Capital Expenditures of $9.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- INSMED INC payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $6.26M, a 79.65% increase year-over-year.
- INSMED INC payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $3.48M, a 65.44% decline year-over-year.
- INSMED INC payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $16.59M, a 144.96% increase year-over-year.
- INSMED INC payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $2.42M, a 34.45% decline year-over-year.
- INSMED INC payments to acquire property, plant, and equipment for fiscal 2025 was $32.56M, a 48.52% increase from fiscal 2024.
- INSMED INC payments to acquire property, plant, and equipment for fiscal 2024 was $21.92M, a 64.98% increase from fiscal 2023.
- INSMED INC payments to acquire property, plant, and equipment for fiscal 2023 was $13.29M, a 34.52% increase from fiscal 2022.
- INSMED INC payments to acquire property, plant, and equipment for fiscal 2022 was $9.88M, a 35.52% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.74M 10-Q · filed 2026-08-06 | $26.33M derived: sum of 3 quarters · filed 2026-08-06 | $28.75M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $3.48M 10-Q · filed 2026-05-07 | $20.07M derived: sum of 2 quarters · filed 2026-05-07 | $22.49M derived: sum of 3 quarters · filed 2026-05-07 | $25.97M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $16.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $19.01M derived: sum of 2 quarters · filed 2026-02-19 | $22.49M derived: sum of 3 quarters · filed 2026-08-06 | $32.56M 10-K · filed 2026-02-19 | ||
| 2025-09-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.90M derived: sum of 2 quarters · filed 2026-08-06 | $15.97M 10-Q · filed 2025-10-30 | $22.74M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $13.55M 10-Q · filed 2026-08-06 | $20.33M derived: sum of 3 quarters · filed 2026-08-06 | $24.02M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $10.07M 10-Q · filed 2026-05-07 | $16.84M derived: sum of 2 quarters · filed 2026-05-07 | $20.53M derived: sum of 3 quarters · filed 2026-05-07 | $27.31M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $6.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.46M derived: sum of 2 quarters · filed 2026-02-19 | $17.24M derived: sum of 3 quarters · filed 2026-02-19 | $21.92M 10-K · filed 2026-02-19 | ||
| 2024-09-30 | $3.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $10.47M derived: sum of 2 quarters · filed 2025-10-30 | $15.15M 10-Q · filed 2025-10-30 | $17.30M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-06-30 | $6.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $11.46M 10-Q · filed 2025-08-07 | $13.62M derived: sum of 3 quarters · filed 2026-02-19 | $16.47M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-03-31 | $4.68M 10-Q · filed 2025-05-08 | $6.83M derived: sum of 2 quarters · filed 2026-02-19 | $9.69M derived: sum of 3 quarters · filed 2026-02-19 | $14.57M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2023-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $5.01M derived: sum of 2 quarters · filed 2026-02-19 | $9.89M derived: sum of 3 quarters · filed 2026-02-19 | $13.29M 10-K · filed 2026-02-19 | ||
| 2023-09-30 | $2.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $7.74M derived: sum of 2 quarters · filed 2024-10-31 | $11.13M 10-Q · filed 2024-10-31 | $15.83M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-06-30 | $4.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $8.28M 10-Q · filed 2024-08-08 | $12.97M derived: sum of 3 quarters · filed 2025-02-20 | $13.55M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-03-31 | $3.40M 10-Q · filed 2024-05-09 | $8.09M derived: sum of 2 quarters · filed 2025-02-20 | $8.67M derived: sum of 3 quarters · filed 2025-02-20 | $11.57M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2022-12-31 | $4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $5.27M derived: sum of 2 quarters · filed 2025-02-20 | $8.18M derived: sum of 3 quarters · filed 2025-02-20 | $9.88M 10-K · filed 2025-02-20 | ||
| 2022-09-30 | $582.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $3.49M derived: sum of 2 quarters · filed 2023-10-26 | $5.19M 10-Q · filed 2023-10-26 | $6.33M derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.61M 10-Q · filed 2023-08-03 | $5.75M derived: sum of 3 quarters · filed 2024-02-22 | $7.23M derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-03-31 | $1.70M 10-Q · filed 2023-05-04 | $2.84M derived: sum of 2 quarters · filed 2024-02-22 | $4.32M derived: sum of 3 quarters · filed 2024-02-22 | $7.81M derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2021-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $2.62M derived: sum of 2 quarters · filed 2024-02-22 | $6.11M derived: sum of 3 quarters · filed 2024-02-22 | $7.29M 10-K · filed 2024-02-22 | ||
| 2021-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $4.97M derived: sum of 2 quarters · filed 2022-10-27 | $6.15M 10-Q · filed 2022-10-27 | $7.08M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-06-30 | $3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.67M 10-Q · filed 2022-08-04 | $5.60M derived: sum of 3 quarters · filed 2023-02-23 | $6.35M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-03-31 | $1.18M 10-Q · filed 2022-05-05 | $2.11M derived: sum of 2 quarters · filed 2023-02-23 | $2.86M derived: sum of 3 quarters · filed 2023-02-23 | $4.74M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2020-12-31 | $933.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.68M derived: sum of 2 quarters · filed 2023-02-23 | $3.56M derived: sum of 3 quarters · filed 2023-02-23 | $6.24M 10-K · filed 2023-02-23 | ||
| 2020-09-30 | $747.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $2.63M derived: sum of 2 quarters · filed 2021-10-28 | $5.31M 10-Q · filed 2021-10-28 | $18.34M derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2020-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $4.56M 10-Q · filed 2021-08-05 | $17.60M derived: sum of 3 quarters · filed 2022-02-17 | $32.19M derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2020-03-31 | $2.68M 10-Q · filed 2021-05-06 | $15.72M derived: sum of 2 quarters · filed 2022-02-17 | $30.31M derived: sum of 3 quarters · filed 2022-02-17 | $40.92M derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2019-12-31 | $13.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $27.63M derived: sum of 2 quarters · filed 2022-02-17 | $38.24M derived: sum of 3 quarters · filed 2022-02-17 | $42.27M 10-K · filed 2022-02-17 | ||
| 2019-09-30 | $14.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $25.20M derived: sum of 2 quarters · filed 2020-10-29 | $29.23M 10-Q · filed 2020-10-29 | $32.26M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-06-30 | $10.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $14.64M 10-Q · filed 2020-08-06 | $17.66M derived: sum of 3 quarters · filed 2021-02-25 | $19.52M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-03-31 | $4.03M 10-Q · filed 2020-04-30 | $7.05M derived: sum of 2 quarters · filed 2021-02-25 | $8.91M derived: sum of 3 quarters · filed 2021-02-25 | $11.75M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $4.88M derived: sum of 2 quarters · filed 2021-02-25 | $7.72M derived: sum of 3 quarters · filed 2021-02-25 | $13.09M 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $4.70M derived: sum of 2 quarters · filed 2019-10-30 | $10.06M 10-Q · filed 2019-10-30 | $11.76M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $8.21M 10-Q · filed 2019-08-01 | $9.91M derived: sum of 3 quarters · filed 2020-02-25 | $10.36M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $5.37M 10-Q · filed 2019-05-07 | $7.07M derived: sum of 2 quarters · filed 2020-02-25 | $7.51M derived: sum of 3 quarters · filed 2020-02-25 | $7.95M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $2.15M derived: sum of 2 quarters · filed 2020-02-25 | $2.58M derived: sum of 3 quarters · filed 2020-02-25 | $3.00M 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $447.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $884.00K derived: sum of 2 quarters · filed 2018-10-30 | $1.30M 10-Q · filed 2018-10-30 | $2.07M derived: sum of 4 quarters · filed 2019-02-22 | ||
| 2017-06-30 | $437.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $854.00K 10-Q · filed 2018-08-02 | $1.63M derived: sum of 3 quarters · filed 2019-02-22 | $2.93M derived: sum of 4 quarters · filed 2019-02-22 | ||
| 2017-03-31 | $417.00K 10-Q · filed 2018-05-02 | $1.19M derived: sum of 2 quarters · filed 2019-02-22 | $2.49M derived: sum of 3 quarters · filed 2019-02-22 | $4.03M derived: sum of 4 quarters · filed 2019-02-22 | ||
| 2016-12-31 | $772.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $2.07M derived: sum of 2 quarters · filed 2019-02-22 | $3.61M derived: sum of 3 quarters · filed 2019-02-22 | $4.20M 10-K · filed 2019-02-22 | ||
| 2016-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $2.84M derived: sum of 2 quarters · filed 2017-11-02 | $3.43M 10-Q · filed 2017-11-02 | $3.83M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-06-30 | $1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.13M 10-Q · filed 2017-08-03 | $2.54M derived: sum of 3 quarters · filed 2018-02-23 | $3.39M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-03-31 | $588.00K 10-Q · filed 2017-05-03 | $995.00K derived: sum of 2 quarters · filed 2018-02-23 | $1.85M derived: sum of 3 quarters · filed 2018-02-23 | $2.78M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2015-12-31 | $407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $1.26M derived: sum of 2 quarters · filed 2018-02-23 | $2.19M derived: sum of 3 quarters · filed 2018-02-23 | $3.45M 10-K · filed 2018-02-23 | ||
| 2015-09-30 | $853.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.78M derived: sum of 2 quarters · filed 2016-11-03 | $3.05M 10-Q · filed 2016-11-03 | $4.58M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-06-30 | $930.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $2.19M 10-Q · filed 2016-08-04 | $3.73M derived: sum of 3 quarters · filed 2017-02-23 | $6.65M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-31 | $1.26M 10-Q · filed 2016-05-05 | $2.80M derived: sum of 2 quarters · filed 2017-02-23 | $5.72M derived: sum of 3 quarters · filed 2017-02-23 | $6.28M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2014-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $4.46M derived: sum of 2 quarters · filed 2017-02-23 | $5.02M derived: sum of 3 quarters · filed 2017-02-23 | $5.35M 10-K · filed 2017-02-23 | ||
| 2014-09-30 | $2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $3.48M derived: sum of 2 quarters · filed 2015-11-06 | $3.81M 10-Q · filed 2015-11-06 | $3.93M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2014-06-30 | $564.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $895.00K 10-Q · filed 2015-08-06 | $1.01M derived: sum of 3 quarters · filed 2016-02-25 | $1.23M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2014-03-31 | $331.00K 10-Q · filed 2015-05-07 | $444.00K derived: sum of 2 quarters · filed 2016-02-25 | $664.00K derived: sum of 3 quarters · filed 2016-02-25 | $994.00K derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2013-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $333.00K derived: sum of 2 quarters · filed 2016-02-25 | $663.00K derived: sum of 3 quarters · filed 2016-02-25 | $826.00K 10-K · filed 2016-02-25 | ||
| 2013-09-30 | $220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $550.00K derived: sum of 2 quarters · filed 2014-11-06 | $713.00K 10-Q · filed 2014-11-06 | $881.00K derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $330.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $493.00K 10-Q · filed 2014-08-06 | $661.00K derived: sum of 3 quarters · filed 2015-02-27 | $688.00K derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $163.00K 10-Q · filed 2014-05-08 | $331.00K derived: sum of 2 quarters · filed 2015-02-27 | $358.00K derived: sum of 3 quarters · filed 2015-02-27 | $387.00K derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $195.00K derived: sum of 2 quarters · filed 2015-02-27 | $224.00K derived: sum of 3 quarters · filed 2015-02-27 | $290.00K 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $56.00K derived: sum of 2 quarters · filed 2013-11-05 | $122.00K 10-Q · filed 2013-11-05 | $546.00K derived: sum of 4 quarters · filed 2014-03-06 | ||
| 2012-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $95.00K 10-Q · filed 2013-08-06 | $519.00K derived: sum of 3 quarters · filed 2014-03-06 | $1.01M derived: sum of 4 quarters · filed 2014-03-06 | ||
| 2012-03-31 | $66.00K 10-Q · filed 2013-05-07 | $490.00K derived: sum of 2 quarters · filed 2014-03-06 | $977.00K derived: sum of 3 quarters · filed 2014-03-06 | $1.03M derived: sum of 4 quarters · filed 2014-03-06 | ||
| 2011-12-31 | $424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $911.00K derived: sum of 2 quarters · filed 2014-03-06 | $965.00K derived: sum of 3 quarters · filed 2014-03-06 | $979.00K 10-K · filed 2014-03-06 | ||
| 2011-09-30 | $487.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $541.00K derived: sum of 2 quarters · filed 2012-11-07 | $555.00K 10-Q · filed 2012-11-07 | -$555.00K 10-Q · filed 2011-11-09 | $555.00K derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $68.00K 10-Q · filed 2012-08-07 | -$68.00K 10-Q/A · filed 2011-08-08 | $68.00K derived: sum of 3 quarters · filed 2013-03-18 | $68.00K derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | $14.00K 10-Q · filed 2012-05-08 | $14.00K derived: sum of 2 quarters · filed 2013-03-18 | $14.00K derived: sum of 3 quarters · filed 2013-03-18 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $0.00 10-K · filed 2013-03-18 | |||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | $0.00 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-08-08 | |||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |